Author details

Full Name

Susan J Little

Affiliation

ORCID

Career Start Year

1994

Papers

242

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34839750	4th Generation HIV screening in the emergency department: net profit or loss for hospitals?	AIDS Care	2023
35732421	Lessons learned from the Last Gift study: ethical and practical challenges faced while conducting HIV cure-related research at the end of life.	J Med Ethics	2023
37738247	Recommendations on data sharing in HIV drug resistance research.	PLoS Med	2023
37561027	Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.	J Infect Dis	2023
37861674	People with HIV at the end of life and their next-of-kin/loved ones are willing to participate in interventional HIV cure-related research.		2023
37034641	Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.	medRxiv	2023
36968957	Predictors of Human Immunodeficiency Virus Pre-Exposure Prophylaxis (PrEP) Uptake in a Sexual Health Clinic With Rapid PrEP Initiation.		2023
37402567	Association between where men who have sex with men (MSM) meet sexual partners and chlamydia/gonorrhoea infection before and during the COVID-19 pandemic in San Diego, California.	Sex Transm Infect	2023
37205592	Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.	Res Sq	2023
36961945	Brief Report: Comparative Analysis of Pre-existing HIV Drug Resistance Mutations in Proviral DNA Using Next-Generation Sequencing and Routine HIV RNA Genotyping.		2023
37392149	Estimating contact network properties by integrating multiple data sources associated with infectious diseases.		2023
37260256	Assessing the reliability of the CD4 depletion model in the presence of Ending the HIV Epidemic initiatives.		2023
37252012	A Community-Driven Framework to Prioritize the Use of Donated Human Biological Materials in the Context of HIV Cure-Related Research at the End of Life.	Pathog Immun	2023
37440872	Perceived risks and benefits of enrolling people with HIV at the end of life in cure research in Southern California, United States.	J Virus Erad	2023
37036397	Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.	Clin Infect Dis	2023
34586088	Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals.	AIDS	2022
36305189	Good2Go: perceptions and impact of a community-based comprehensive sexual health screening program in San Diego, California.	AIDS	2022
36357712	Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.	Nat Microbiol	2022
35898343	SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.	medRxiv	2022
36016455	HIV but Not CMV Replication Alters the Blood Cytokine Network during Early HIV Infection in Men.	Viruses	2022
35441174	Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial.	medRxiv	2022
34287757	A Cross-Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men.	AIDS Behav	2022
35012544	Ethical and practical considerations for HIV cure-related research at the end-of-life: a qualitative interview and focus group study in the United States.	BMC Med Ethics	2022
34427814	Correction to: A Crossâ¿¿Sectional Study to Evaluate the Effects of Age and Duration of HIV Infection on Anxiety and Depression in Cisgender Men.	AIDS Behav	2022
34587382	Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.	N Engl J Med	2021
32266376	Phylogenetic Cluster Analysis: Persons With Undiagnosed Infection Drive Human Immunodeficiency Virus Transmission in a Population With High Levels of Virologic Suppression.	Clinical Infectious Diseases	2021
34127579	Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria.	AIDS	2021
33961653	Attitudes and perceptions of next-of-kin/loved ones toward end-of-life HIV cure-related research: A qualitative focus group study in Southern California.	PLoS One	2021
33849057	MrHAMER yields highly accurate single molecule viral sequences enabling analysis of intra-host evolution.	Nucleic Acids Research	2021
34110736	The Performance of Pooled 3 Anatomic Site Testing for Chlamydia trachomatis and Neisseria gonorrhoeae Among Men Who Have Sex With Men and Transgender Women.	Sexually Transmitted Diseases	2021
34270612	Ethical and practical considerations for interventional HIV cure-related research at the end-of-life: A qualitative study with key stakeholders in the United States.	PLoS One	2021
33511237	Integrase Strand Transfer Inhibitors Play the Main Role in Greater Weight Gain Among Men With Acute and Early HIV Infection.	Open Forum Infectious Diseases	2021
33560092	Interest, Concerns, and Attitudes Among Men Who Have Sex With Men and Health Care Providers Toward Prophylactic Use of Doxycycline Against Chlamydia trachomatis Infections and Syphilis.	Sexually Transmitted Diseases	2021
34324256	Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.	Transplant Infectious Disease	2021
32767155	Biometric Registration to an HIV Research Study may Deter Participation.	AIDS and Behavior	2021
33314418	HIV screening in emergency departments: Linkage works but what about retention?	Acad Emerg Med	2021
33079188	Dynamics and Dispersal of Local Human Immunodeficiency Virus Epidemics Within San Diego and Across the San Diego-Tijuana Border.	Clin Infect Dis	2021
32777035	Rapid Antiretroviral Therapy Among Individuals With Acute and Early HIV.	Clinical Infectious Diseases	2021
34550966	Incorporating metadata in HIV transmission network reconstruction: A machine learning feasibility assessment.	PLoS Comput Biol	2021
34492694	Effective Human Immunodeficiency Virus Molecular Surveillance Requires Identification of Incident Cases of Infection.	Clin Infect Dis	2021
30953067	Genetic Network Analysis to Assess the Risk of Human Immunodeficiency Virus Transmission Among Men Who Have Sex With Men Seeking Partners on the Internet.	Clin Infect Dis	2020
31677383	Grindr Users Take More Risks, but Are More Open to Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis: Could This Dating App Provide a Platform for HIV Prevention Outreach?	Clin Infect Dis	2020
32055638	Optimizing Screening for HIV.	Open Forum Infect Dis	2020
31713432	I wanted it as soon as possible: a qualitative exploration of reactions to access to same-day ART start among participants in San Diego's ART-NET project.	AIDS Care	2020
31560741	Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid.	Clin Infect Dis	2020
32449625	"My Death Will Not [Be] in Vain": Testimonials from Last Gift Rapid Research Autopsy Study Participants Living with HIV at the End of Life.	AIDS Res Hum Retroviruses	2020
32449624	Perceptions of Next-of-Kin/Loved Ones About Last Gift Rapid Research Autopsy Study Enrolling People with HIV/AIDS at the End of Life: A Qualitative Interview Study.	AIDS Research and Human Retroviruses	2020
33206710	"[It] is now my responsibility to fulfill that wish:" Clinical and rapid autopsy staff members' experiences and perceptions of HIV reservoir research at the end of life.	PLoS One	2020
32525980	Addressing Ethical Challenges in US-Based HIV Phylogenetic Research.	J Infect Dis	2020
33085643	Bayesian reconstruction of transmission trees from genetic sequences and uncertain infection times.	Stat Appl Genet Mol Biol	2020